Bavarian Nordic A/S (BVNRY)
9.30
+0.05
(+0.54%)
USD |
OTCM |
Jun 09, 16:00
Bavarian Nordic SG&A Expense (Quarterly) : 47.93M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Evaxion AS | 1.527M |
| Genmab A/S | 166.61M |
| Ascendis Pharma A/S | 169.91M |
| Zealand Pharma A/S | 16.29M |
| Agenus, Inc. | 6.86M |